Uterine Cancer Clinical Trials

23 recruiting

Frequently Asked Questions

Common questions about Uterine Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Phase 2

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Cervical CancerEndometrial CancerUterine Cancer
Abramson Cancer Center at Penn Medicine25 enrolled3 locationsNCT05758688
Recruiting

Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking

Uterine Cancer
Duke University17 enrolled1 locationNCT05977621
Recruiting
Phase 1Phase 2

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab764 enrolled67 locationsNCT05579366
Recruiting
Phase 2

Azenosertib in Uterine Serous Carcinoma: Biomarker Study

Uterine CancerUterine Serous CarcinomaUterine Carcinoma
Joyce Liu, MD25 enrolled2 locationsNCT06369155
Recruiting

Cancer Loyalty Card Study 2 (CLOCS-2)

Liver CancerPancreatic CancerOvarian Cancer+7 more
Imperial College London2,900 enrolled1 locationNCT06447064
Recruiting

Sample Collection for Ongoing Research and Product Evaluation Study

Breast CancerLiver CancerPancreatic Cancer+9 more
Natera, Inc.9,600 enrolled1 locationNCT07318051
Recruiting
Not Applicable

Image-Guided Gynecologic Brachytherapy

Cervical CancerBladder CancerUterine Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins54 enrolled1 locationNCT02993900
Recruiting
Phase 1

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Endometrial CancerUterine Cancer
Washington University School of Medicine36 enrolled4 locationsNCT06795009
Recruiting

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

Breast CancerOvarian CancerLung Cancer+15 more
University Health Network, Toronto2,500 enrolled1 locationNCT03702309
Recruiting
Phase 1

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Breast CancerOvarian CancerCervical Cancer+6 more
M.D. Anderson Cancer Center40 enrolled1 locationNCT04038619
Recruiting
Phase 2

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Ovarian CancerCervical CancerEndometrial Cancer+5 more
Dana-Farber Cancer Institute32 enrolled2 locationsNCT06677190
Recruiting
Not Applicable

Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery

Gynecologic CancerUterine CancerGynecologic Disease+1 more
Stanford University50 enrolled1 locationNCT07044505
Recruiting

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

Breast CancerLiver CancerGastric Cancer+9 more
Washington University School of Medicine10 enrolled1 locationNCT06904365
Recruiting

Investigations of Reproductive Cancers in Women

Uterine Cancer
PinkDx, Inc.4,500 enrolled16 locationsNCT06527157
Recruiting

Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy

Ovarian CancerCervical CancerEndometrial Cancer+5 more
Aesculap AG132 enrolled2 locationsNCT06024109
Recruiting
Phase 2

[18F]FES PET/.CT in Uterine Cancer

Uterine Cancer
Abramson Cancer Center at Penn Medicine30 enrolled1 locationNCT05916196
Recruiting
Phase 1Phase 2

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

Endometrial CancerCarcinomaGynecologic Cancer+1 more
University of Alabama at Birmingham37 enrolled1 locationNCT05559879
Recruiting
Not Applicable

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Cervical CancerEndometrial CancerUterine Cancer+4 more
Northwestern University192 enrolled1 locationNCT05743517
Recruiting
Phase 1Phase 2

Study of NEO-201 in Solid Tumors Expansion Cohorts

Cervical CancerNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+1 more
Precision Biologics, Inc121 enrolled2 locationsNCT03476681
Recruiting

NYSCF Scientific Discovery Biobank

Ovarian CancerCervical CancerDiabetes Mellitus+26 more
New York Stem Cell Foundation Research Institute10,000 enrolled1 locationNCT06203106